Unknown OBSERVATIONAL NCT00894296

Magnetoencephalographic (MEG) Correlates of Negative Symptoms in Patients Suffering From Schizophrenia and Their Influence by Add-on Treatments

Sponsor: Bar-Ilan University, Israel

Updated 7 times since 2017 Last updated: Jan 4, 2012 Started: Mar 31, 2009 Primary completion: Jan 31, 2013 Completion: Jan 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00894296, this observational or N/A phase trial focuses on Schizophrenia and remains ongoing. Sponsored by Bar-Ilan University, Israel, it has been updated 7 times since 2009, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Jun 2018 — Jan 2021 [monthly]

Unknown Status
Apr 2018 — Jun 2018 [monthly]

Unknown Status

Phase: EARLY_PHASE1 → None

▶ Show 2 earlier versions

Feb 2017 — Apr 2018 [monthly]

Unknown Status EARLY_PHASE1

Phase: Phase 0 → EARLY_PHASE1
Jan 2017 — Feb 2017 [monthly]

Unknown Status Phase 0

First recorded

Mar 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bar-Ilan University, Israel
Shalvata Mental Health Center

Data source: Shalvata Mental Health Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Givat Shmuel, Israel